- Home
- WTI vs TARA Comparison
WTI vs TARA Comparison
Compare WTI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTI | TARA |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 309.5M | 268.5M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | WTI | TARA |
|---|---|---|
| Price | $2.26 | $6.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | ★ 2.4M | 878.7K |
| Earning Date | 03-02-2026 | 03-04-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $500,094,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $2.77 |
| 52 Week High | $2.65 | $7.82 |
Technical Indicators
Market Signals| Indicator | WTI | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 56.79 | 56.85 |
| Support Level | $2.04 | $6.23 |
| Resistance Level | $2.65 | $6.69 |
| Average True Range (ATR) | 0.16 | 0.43 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 42.06 | 31.43 |
Price Performance
Historical ComparisonAbout WTI W&T Offshore Inc.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).